AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
4 Min Read

AMA finds competition decline among drug middlemen

AMA releases updated analysis of competition and vertical integration in commercial PBM markets

Press Releases
Copy
Hand of a patient on IV drip receiving a saline solution
·
5 Min Read

Reforms needed to alleviate persistent drug shortages

Federal regulators and Congress need to act now to eliminate persistent drug shortages that threaten patient health and well-being.

series
Leadership
Leadership Viewpoints
Copy
Prescription pill bottle
·
12 Min Read

What doctors wish patients knew about anti-obesity medication

Over 40% of Americans have obesity and biological realities make weight loss hard to sustain. Learn more with two obesity medicine physicians.

series
Chronic Diseases
What Doctors Wish Patients Knew™
Copy
Person holding a bottle of nutritional supplement capsules
·
8 Min Read

Questions patients may have about weight-loss drugs

The rise in popularity of Wegovy, Ozempic and other anti-obesity medications, has led to more questions among patients with obesity or type 2 diabetes.

Behavioral Health
Copy
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 29, 2023

In the news: Eligible Americans lose Medicaid coverage, impact of exercise on brain health, FDA issues warning on off-brand semaglutide and more.

Publications & Newsletters
Copy
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of May 22, 2023

In the news: Benefits of semaglutide, surgeon general warns of social media risks, implants help paralyzed man walk, key long COVID symptoms identified and more.

Publications & Newsletters
Copy
·
10 Min Read

May 19, 2023: National Advocacy Update

 Senate Committee passes bipartisan PBM legislation and more in the latest National Advocacy Update.

Advocacy Update
Copy
·
1 Min Read

AMA statement on DEA extending telehealth prescription flexibilities

The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.

Press Releases
Copy
Mifepristone
·
5 Min Read

Next steps in mifepristone court fight: What doctors should know

Federal appeals court will hear arguments on order that would prevent access to a safe and effective reproductive health care option. Learn more.

Judicial Advocacy
Copy